Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial
作者
Bertrand Coiffier,Evgenii A. Osmanov,Xiaonan Hong,Adriana Scheliga,Jiřı́ Mayer,Fritz Offner,Simon Rule,Adriana Teixeira,Jan Walewski,Sven de Vos,Michael Crump,Ofer Shpilberg,Dixie‐Lee Esseltine,Eugene Zhu,Christopher Enny,Panteli Theocharous,Helgi van de Velde,Yusri Elsayed,Pier Luigi Zinzani